3 year old little sister umbilical cord blood to bring hope to the age of 5 Lu Lu – Sohu maternal xxjjyy.com

3 year old little sister of umbilical cord blood to 5 year old Lu Lu hope to Sohu maternal and child 5 year old Lu Lu unfortunately suffered blood disease threats — aplastic anemia. Lu Lu’s father and mother, Lu Lu often pale, fatigue, dizziness, have a fever, and skin bruises, hurried to the hospital to do blood tests, was diagnosed with aplastic anemia. Since then, Lu Lu’s childhood in the shadow of light of heart from care, mom and Dad had to take her everywhere, do battle. There are many children suffering from Lu Lu’s suffering. According to China’s 21 provinces in the survey, 100 thousand in every 1.87 to 2.1 people suffering from aplastic anemia can occur in patients of all ages and children easily induced acute aplastic anemia. Capital Institute of Pediatrics Department of Hematology director Shi Xiaodong said that aplastic anemia is a serious harm to children’s health and life of the disease, if not effective treatment can lead to death, especially acute aplastic anemia mortality rate is high, must be early detection and early treatment if timely treatment, the cure rate of up to 70%, and can completely cure. At the beginning of this year, Lu Lu was sent to the General Hospital of Chengdu Military Region for treatment, fortunately, bone marrow and Lu Lu matching mother of success, after careful study, the hospital decided the bone marrow and peripheral blood stem cell transplantation combined with the mother to Lu Lu, in order to make the probability of successful transplantation is higher, in October 14th, to the hospital and Sichuan cord blood bank issued the query application, search a suitable umbilical cord blood as adjuvant therapy after transplantation. "The treatment of severe aplastic anemia by the standard, namely, hematopoietic stem cell transplantation and enhancement of immune therapy, can make patients have a greater chance of cure." Peking Union Medical College Hospital chief physician professor Han Bing pointed out that "although the therapeutic value of hematopoietic stem cell transplantation has attracted much attention, but many patients have to face the lack of consistency of stem cell donor cruel reality, because many patients do not have to wait until a suitable donor and regret from the world." There are three major sources of hematopoietic stem cells, bone marrow, peripheral blood and cord blood. The umbilical cord blood of a fetus, umbilical cord ligation and transection left in the placenta and umbilical cord blood, after the medical practice in recent decades that is rich in hematopoietic stem cells in umbilical cord blood, with reconstruction of the blood and immune system function. Umbilical cord blood hematopoietic stem cell transplantation has the advantages of high safety, small rejection, strong proliferation ability and high survival rate. Because the cord blood bank is the physical library, after the success of the matching can be used at any time, can shorten the time to find hematopoietic stem cells, to avoid delay condition. The hospital received Sichuan umbilical cord blood bank query application, by matching the query to find a suitable cord blood for Lu Lu. The umbilical cord blood donated in May 23, 2013 by the Chengdu, Ms. Lu Lu, and the 56 sites consistent, after the detection of active, fully in line with the clinical use of standards. In October 24th, the hospital was determined using the umbilical cord blood, which will be held on October 28th was sent to the General Hospital of Chengdu Military Region, helping Lu Lu to rekindle the fire of life. Sun Yuan, director of Hematology Oncology Center of Beijing children’s Hospital of Kyoto, has more than 20 years of clinical experience, specializes in the use of hematopoietic stem cells.相关的主题文章: